PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicare Advantage · Prior Auth · Pharmacy · FL, SC, IN, OK, VA · PharmacyMedium impact

Drug Utilization Management and Clinical Edits Tools (Revised)

Effective date
Aug 28, 2010
Identified
Jun 25, 2026

Summary

This is a guidance policy update (revised November 26, 2025) that clarifies Humana's Drug Utilization Management and Clinical Edits Tools across Medicare and multiple state Medicaid programs. The policy outlines how Humana applies prospective clinical edits (prior authorization, quantity limits, step therapy, duplication edits, drug/drug interactions, accumulation edits, and age/gender/disease/pregnancy edits) to ensure safe and cost-effective medication therapy. The policy specifies grandfathering exceptions for four drug classes (antidepressants, antipsychotics, anticonvulsants for epilepsy, antineoplastics, antiretrovirals, and immunosuppressants) and clarifies that drug samples do not count as treatment experience for prior authorization or step therapy requirements.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

Action · 8 steps
01REQUIREMENTS: By December 31, 2025 (to align with new plan year implementation): Billing and pharmacy teams must review and update their prior authorization and step therapy protocols to reflect Humana's clinical edit tools as described in this revised guidance.
02Ensure PA/ST systems accurately distinguish between grandfathered drug classes (antidepressants, antipsychotics, anticonvulsants for epilepsy, antineoplastics, antiretrovirals, immunosuppressants) and non-grandfathered drugs.
03Configure systems to reject claims for new starts on non-grandfathered drugs requiring PA/ST—drug sample history does NOT override this requirement.
04Update prior authorization request forms to document whether the member is a 'new start' or 'treatment-experienced'.
05Train prior authorization staff that drug samples are NOT evidence of treatment experience for the requested drug.
06For members stable on grandfathered medications, ensure approval processes review diagnosis, coverage limitations, disease progression, and ECOG staging as appropriate.
07Consequences of inaction: Claims will be denied for new starts on non-grandfathered drugs without prior authorization, and appeals will be denied if drug sample history is cited as evidence of treatment experience.
08This affects all prescription drug claims submitted to Humana Medicare Advantage and Medicaid plans in FL, SC, IN, OK, and VA.

Original notice

Drug Utilization Management and Clinical Edits Tools (Revised)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account